The Health Care Authority (HCA) has issued an interim updated
hepatitis C policy that reflects the rapidly changing field of treatment
for the chronic disease. The policy will be presented to the Washington
State Drug Utilization Board for final approval in February.
There are several key updates in the policy, which applies to Medicaid clients.
- Those infected with hepatitis B or HIV now qualify for hepatitis C
treatment if they have moderate liver scarring. In the previous policy,
only those with severe liver disease and other specific conditions,
including those receiving an organ transplant, qualified for the
- People with a history of intravenous drug use may be treated right
away if they meet the treatment qualifications. In the previous policy,
individuals had to have not used IV drugs for the past six months, with
- The policy provides guidance on when it is not appropriate to offer hepatitis C treatment.
View the updated policy.
Labels: Medicaid policy, Washington state